Indian Pharmacopoeia Commission: Chairman Of
The IPC operates under a unique leadership model that bridges administrative oversight with deep scientific expertise.
| Pillar | Specific Duties | Strategic Challenge | | :--- | :--- | :--- | | | Final approval of new monographs, revisions of IP | Keeping pace with complex generics (e.g., liposomal injections) | | Regulatory Interface | Liaison with CDSCO on recall triggers & quality alerts | Resisting industry lobbying to lower standards | | International Harmonization | Representing India at PDG (Pharmacopoeial Discussion Group) | Balancing WHO prequalification vs. local manufacturing realities | | Public Health Crises | Rapid issuance of standards for new drugs (e.g., COVID-19 repurposed drugs) | Ensuring quality without delaying emergency access |
Acts as the Chief Scientific and Executive Officer, managing day-to-day operations and coordinating between the three bodies. Roles and Responsibilities chairman of indian pharmacopoeia commission
The day-to-day scientific and executive functions are managed by the Secretary-cum-Scientific Director . As of June 25, 2025, Dr. Vivekanandan Kalaiselvan has assumed this vital role. Who is Dr. Vivekanandan Kalaiselvan? Dr. Kalaiselvan
The Chairman’s primary mandate is to facilitate the timely publication of the , the official book of standards for drugs in India under the Drugs and Cosmetics Act, 1940. Key responsibilities include: The IPC operates under a unique leadership model
Beyond the publication of books, the Chairman oversees the Indian Pharmacopoeia Reference Substances (IPRS), which are the chemical reference standards required to test drugs. Without these standards, the regulations in the Pharmacopoeia cannot be enforced. Ensuring the uninterrupted supply and purity of IPRS is a logistical and scientific challenge that falls under the Chairman's purview. Furthermore, the Chairman drives the pharmacovigilance program of India (PvPI). This initiative monitors the safety of drugs in the market, collecting data on adverse drug reactions. By championing this program, the Chairman helps create a safety net that identifies harmful drugs or formulations, allowing for timely regulatory interventions that save lives.
Chaired by the Union Health Secretary (Chairman of IPC), this body oversees the commission’s overall policies and financial allocations. Who is Dr
Led by a Co-Chairman (typically an eminent scientist or former health official), this body focuses on the technical standards for drug monographs.